One of the world’s largest medical device companies is accused of deliberately misleading patients and doctors over the effectiveness of an implant for back pain.
Australia’s medical regulator made the serious allegation in a confidential report obtained by this masthead, in a revelation that raises fresh questions about the company that dominates the multibillion-dollar medical device market.
Medtronic, a $US118 billion ($165 billion) medical giant, tells patients and doctors on its website that its expensive Intellis spinal cord stimulator cuts back pain by more than half in the vast majority of patients. That claim is based on a 128-person…
Read the full article at SMH.COM.AU
